Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simultaneous Study of Docetaxel-Based Anthracycline-Free Regimen in Breast Cancer
2008-005453-38Phase 3Completed
- Sponsor
- University Hospital Ulm
- Start
- Oct 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of docetaxel in breast cancer (2 arms), sponsored by University Hospital Ulm. Primary endpoint: Disease-free survival. Started Oct 2008; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-005453-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005453-38.